One of the biggest hurdles in pediatric cardiology has always been that "mechanical valves don't grow," but 2026 is bringing us closer to a biological solution: Tissue-Engineered Bioresorbable Scaffolds. In 2026, early-stage clinical trials are exploring valves that use a biodegradable "skeleton" seeded with the patient's own cells. As the child grows, the scaffold slowly dissolves, leaving...